Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr₹776 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹-1,502 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-1,502 Cr
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr
Mar2021₹776 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-1,502 Cr
Negative
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr
25.01
Mar2021 ₹776 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,110.4 Cr -1.6% -8.8% 49.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -0.7% -3.6% 6% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr 1.1% -1.2% -0.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr 1.6% 1.4% 36.7% Stock Analytics
CIPLA ₹113,155.0 Cr 0.7% 2.6% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,652.0 Cr -0.9% -2.5% 1.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.6%

-8.8%

49.7%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses